ArticleJCEM case reports2026
Unexpected resolution of chronic gastroesophageal reflux disease with testosterone replacement therapy.
Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 63-year-old man with a chronic, 30-year, history of gastroesophageal reflux disease (GERD) that required long-term proton pump inhibitor (PPI) use experienced complete symptom resolution after initiation of testosterone replacement therapy (TRT) for symptomatic hypogonadism. After 11 months of TRT, the patient inadvertently discontinued PPI therapy (esomeprazole 20 mg once daily) while away on vacation without any of the expected rebound acid hypersecretion he had previously experienced in the past when trying to stop. Three months post-PPI cessation, he remained asymptomatic with no requirement for antireflux medication. This case presents a novel and unexpected beneficial effect of TRT on the symptoms of GERD and contrasts with current literature that suggest hormone replacement therapy, with estrogen and progesterone, typically exacerbates reflux disease. Mechanisms behind this improvement may involve anti-inflammatory properties of testosterone, a direct effect on lower esophageal sphincter tone and improved gastric motility, or indirect benefits through weight loss and increased physical activity. Or, as is most likely, a combination of several factors. This paper highlights the need for further investigation into the relationship between testosterone and gastrointestinal physiology in men with hypogonadism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.